Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

about

Pharmacogenetic considerations in the treatment of HIV.

P2860

Q38782609-0E7045C2-6C5A-48A6-910F-B8C924D6C913

P2860

Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

Item

http://www.wikidata.org/entity/Q41048998

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Can antiretroviral therapy be ...... ual? Role of pharmacogenomics.

@en

type

Item

label

Can antiretroviral therapy be ...... ual? Role of pharmacogenomics.

@en

prefLabel

Can antiretroviral therapy be ...... ual? Role of pharmacogenomics.

@en

P1476

Can antiretroviral therapy be ...... ual? Role of pharmacogenomics.

@en

P2093

Eulalia Valle-Garay

http://www.w3.org/2001/XMLSchema#string

Julio Collazos

http://www.w3.org/2001/XMLSchema#string

Victor Asensi

http://www.w3.org/2001/XMLSchema#string

P2860

No influence of the P-glycoprotein polymorphisms MDR1 G2677T/A and C3435T on the virological and immunological response in treatment naïve HIV-positive patients

The role of drug transporters in the kidney: lessons from tenofovir

Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals.

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy.

CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.

The pharmacogenomics of HIV therapy.

P304

169-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.5501/WJV.V4.I3.169

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281143555

http://www.w3.org/2001/XMLSchema#string

P698

26279978

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

P932

4534808

http://www.w3.org/2001/XMLSchema#string

Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

about

P2860

P2860

Can antiretroviral therapy be tailored to each human immunodeficiency virus-infected individual? Role of pharmacogenomics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932